FRANKFURT, Germany and MIAMI, March 17, 2025 (GLOBE NEWSWIRE) -- Partex NV and Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company, today announced a ...

Partex and Fortress Biotech announce collaboration to enhance biopharmaceutical compound evaluation using AI-driven technology.

Parexel, a global CRO, will collaborate with digital pharma platform provider Partex to leverage AI in pursuit of drug discovery and development of biotech as well as to streamline clinical trials ...

Partex And Fortress Biotech Announce Collaboration To Accelerate Biopharma Asset Evaluation March 17, 2025 — 11:44 am EDT Written by RTTNews.com for RTTNews -> ...